A study in Alzheimer's & Dementia has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for ...

A study in Alzheimer's & Dementia , a leading journal in dementia research, has demonstrated the high accuracy of plasma p-tau217 as a blood-based ...

Is there a link between age-related macular degeneration and Alzheimer's disease? Age-related macular degeneration, or AMD, is a common eye condition and also a leading cause of vision loss among ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

“This follow-up study of gantenerumab, an anti-amyloid drug that previously failed to slow cognitive decline in people at risk of Alzheimer’s disease, suggests that extended use of anti-amyloid ...

Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study Systemic exposure following subcutaneous administration ...

Scientists have uncovered the first evidence of Alzheimer's disease transmission in living individuals, marking a significant ...

A protein that impacts Alzheimer’s disease offers new opportunities for targeted treatments, although its cell-specific ...

A groundbreaking peer-reviewed Thought Leaders Invited Review article in Brain Medicine (Genomic Press, New York) explores how CD2-associated protein (CD2AP) contributes to Alzheimer's disease (AD), ...